Immune Regulation


CellR4 2020; 8: e2850
DOI: 10.32113/cellr4_20205_2850

Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

CellR4 2017; 5 (5): e2435

Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes

CellR4 2016; 4 (5): e2134

Clinical trials of mesenchymal stem cell transplantation in patients with type 1 diabetes and systemic lupus erythematosus: is it time for larger studies?